INTRODUCTION
Monoamine oxidase (MAO. EC 1.4.3.4) is a flavoenzyme tightly associated with the outer mitochondrial membrane. There are two forms (MAO-A and MAO-B) with 70% amino acid homology, coded for by two separate genes on the X chromosome (Bach et al. 1988) .
Monoamine oxidases metabolise amines to their corresponding aldehydes, with hydrogen peroxide (H 2 O 2 ) and ammonia as by-products. MAO controls neurotransmitter levels and intracellular amine stores. The two isoforms have distinct substrate and inhibitor specificities, with MAO-A, for example, preferentially deaminating 5-hydroxytryptamine (serotonin, and inhibited by low concentrations of clorgyline (Fowler and Tipton, 1984) . The MAO isoforms are differentially expressed in the CNS and peripheral tissues (reviewed by Billett, 2004) . In human brain MAO-A is highly expressed in catecholaminergic neurons, including the dopaminergic neurons of the substantia nigra pars compacta (SNpc). In contrast, MAO-B is found in serotonergic neurons and astrocytes. It has been suggested that age-related increases in glial MAO-B expression may contribute to the aetiology of Parkinson's disease (PD) (Kumar et al. 2003) whilst MAO-A deficiency leads to aggressive behaviour in mice and humans (Shih et al. 1999) .
Oxidative stress results from an imbalance of antioxidant defence mechanisms and generation of reactive oxygen species (ROS). ROS are important mediators in an array of biological processes, including cell growth (Yoon et al. 2002) , cell signalling and apoptosis (Finkel, 1998) . ROS have been implicated in various forms of cell death (Tatton and Olanow, 1999) , and a range of pathological conditions including neurodegeneration (Schulz et al. 2000) . Oxidative stress has particular relevance to PD, a disorder that causes damage to nigrostriatal dopaminergic neurons, F o r P e e r R e v i e w 4 because dopamine itself can undergo autooxidation which can result in structural modification of proteins (Stokes et al. 1999) and have deleterious effects on cellular respiration (Berman and Hastings, 1999) . Vulnerability of neurons to attack by free radicals is heightened by their low glutathione content, which in PD is further reduced (Riederer et al. 1989) .
A major source of ROS in the cell is the mitochondrial generation of superoxide anion due to respiration (Abou-Sleiman et al. 2006) . In addition, oxidative deamination of biogenic amines by MAO is a key contributor to increased steady state concentrations of ROS (Cadenas and Davies, 2000) . In dopaminergic neurons extravesicular dopamine is metabolised by MAO to produce H 2 O 2 , which is further converted to hydroxyl radicals. Metabolism of amines by MAO causes oxidative damage to mitochondrial DNA (Hauptmann et al. 1996) and directly damages the electron transport system and affects antioxidant defence systems (Cohen and Kesler, 1999) . Additionally, subtle increases in H 2 O 2 production caused by up-regulation of MAO-B in the rat neuroblastoma cell line PC12 decreased mitochondrial complex I activity (Kumar et al. 2003) .
The role of MAO-A in dopaminergic cell death has been the focus of recent publications. It was reported that induction of apoptosis by nerve growth factor deprivation in rat PC12 cells was paralleled by an increase in MAO-A expression (DeZutter and Davis, 2001 ). This regulatory process involved the p38 MAPK signal transduction pathway. On the contrary, MAO-A has been found to be a target of a dopaminergic neurotoxin, N-methyl-R-salsolinol, and that in this case inhibition of MAO led to apoptosis in the human neuroblastoma SH-SY5Y cell line (Yi et al. 2006) . Most recently, Ou and co-workers (Ou et al. 2006) have reported that growth factor deprivation via serum withdrawal led to a concomitant reduction in the transcription repressor In order to explore whether MAO-A is a key player in neuronal apoptosis we tested its impact in another well established apoptotic model (staurosporine treated SH-SY5Y cells; Lopez and Ferrer, 2000) . Staurosporine is an unspecific protein kinase inhibitor which has frequently been used as an inducer of the mitochondrial apoptotic pathway (Lopez and Ferrer, 2000) . In this study we monitored apoptosis via analysis of caspase activation and explored whether apoptosis was linked to changes in MAO expression and activity, and how ROS and the MAPK pathways were contributing to apoptotic cell signalling. anti-Bcl-2 monoclonal antibody, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and ascorbic acid (vitamin C) were purchased from Sigma Aldrich (Dorset, U.K). 2`, 7`-Dichlorodihydrofluorecein diacetate (DCDHF) was obtained from Alexis Biochemicals (Nottingham, UK). Anti-active caspase-8 and anti-active caspase-9 antibodies were purchased from Upstate Biotechnology (Hampshire, UK). Anti-phosphorylated ERK, total ERK and anti- Anti-phosphorylated p38 and total JNK antibodies were from Cell Signalling Technology (Hertfordshire, UK). Total p38 antibody was purchased from New England Biolabs (MA, U.S.A). Anti-MAO-A (6G11-E1) and anti-MAO-B (3F12-G10-2E3) monoclonal antibodies were made in our laboratory. Secondary antibodies were purchased from DakoCytomation (Cambridgeshire, UK). Oligonucleotides were obtained from Biotez (Berlin, Germany).
MATERIALS AND METHODS

Materials
Cultures
Human neuroblastoma SH-SY5Y cells were seeded at a density of approximately 4×10 4 cells/cm 2 on plastic culture plates, flasks (Starsted, Nümbrecht, Germany) or Lab-Tek® chamber slides (NUNC, Roskilde, Denmark) and grown to 75-80 % confluence in DMEM HAM's-F12 medium containing 10 % (v/v) foetal bovine serum, 2 mM L-glutamine, 1 % (v/v) non-essential amino acid solution, 100 units ml -1 penicillin and 100 µg ml -1 streptomycin at 37°C in a 5% CO 2 humidified atmosphere.
Fluorogenic caspase-3 activation assay
Caspase activity was monitored using a fluorogenic based assay with Acetyl-Asp-GluVal-Asp-7-amidomethylcoumarin (Ac-DEVD-AMC) as substrate. Briefly, 500,000 cells were seeded into 25cm 3 flasks. On reaching 70-80% confluence the cells were pre-incubated for 2 h with the required inhibitor then treated for 0-8 h with STS. After treatment both adherent and floating cells were harvested by centrifugation at 300×g for 5 min. The pellet was washed twice with DMEM, resuspended in 200-300 µl lysis buffer (50 mM HEPES, 5 mM CHAPS, 5 mM DTT, pH 7.4) and incubated on ice for 20 min. The lysates were centrifuged at 200×g at 4°C for 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Data were normalised for protein content, which was determined by the Lowry method (Lowry et al. 1951 ) and expressed as fluorescence units/min/µg protein.
MTT reduction assay
SH-SY5Y cells were plated in 96-well plates at a density of ~ 20,000 cells/well and grown to ~70-80 % confluence. Cell viability was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction assay. Briefly, following pre-treatment for 2 h with the required inhibitors, the cells were treated with 1µM STS in the presence and absence of the MAO inhibitors. MTT stock solution in phosphate-buffered saline was added to each well at a final concentration of 0.5 mg/ml and incubated for 30 min. The dark blue formazan crystals formed in intact cells were solubilised in 100 µl of dimethylsulfoxide and the absorbance measured at 595 nm with a microtitre plate reader (Bio-Rad model 680, California, U.S.A).
Results are expressed as mean percent MTT reduction of the relevant control.
MAO activity assay
MAO activity was monitored using a radiometric assay with 14 C-labelled tyramine hydrochloride as substrate, based on the method of Russell and Mayer (Russell and Mayer, 1983) with modifications. anti-mouse or anti-rabbit immunoglobulin G (dilution 1:1000). Antibody binding was revealed with the ECL Western blotting detection reagent (Pierce, Rockford, Illinois, and U.S.A). Digital images were captured using a LAS-3000 image-analyser (Fuji Film Co. Ltd., Tokyo, Japan), and band intensity quantified using Aida software (Raytest GmbH, Straubenhardt, Germany).
Dot blotting
Treated cells were harvested, as previously described, and resuspended in 150 µl MAO extraction buffer (50 mM Tris, 150 mM NaCl, 5 mM EDTA, 1 mM Na orthovanadate, 0.5 % phosphate. Digital images were captured using a LAS-3000 image-analyser (Fuji Film Co. Ltd., Tokyo, Japan), and band intensity quantified using Aida software (Raytest GmbH, Straubenhardt, Germany).
Detection of Reactive Oxygen Species (ROS)
Cells were grown to ~70-80 % confluence on Lab-Tek (NUNC, Rosklide, Denmark) chamber slides prior to pre-treatment for 2 h with either serum free medium, 1 mM N- Following incubation the dye was replaced with either HBSS media alone (control), 500 µM H 2 O 2 (positive control) or 1 µM STS in the presence or absence of 1 mM NAC or 1 mM Vitamin C for 1.5 h. The concentration of anti-oxidants used was based on viability assays (using the MTT assay, data not shown) and information from previously published work (Spina et al. 1992) . Changes in DCDHF fluorescence were monitored using a Leica CLSM inverted confocal laser scanning microscope. Increase in cytosolic dichloro-fluorescein (DCF) fluorescence reflected elevated intracellular ROS production. All images were taken using the same laser power, gain and objective. 
Quantitative and conventional RT-PCR
Total RNA was isolated from SH-SY5Y cells using the RNeasy Mini Kit (Qiagen, Hilden, Germany) and was reversely transcribed into the corresponding cDNA using oligo d(T) 18 and Superscript II reverse transcriptase (Invitrogen, Karlsruhe, Germany) according to the vendors instructions. Quantitative PCR was carried out with a Bio-Rad iCycler system, using the iQ SYBR Green Supermix kit from Bio-Rad (Bio-Rad, California, U.S.A). The following primers were used: MAO A, 5'-GCC CTG TGG TTC TTG TGG TAT GT-3', 5'-TGC TCC TCA CAC CAG TTC TTC TC-3' and GAPDH, 5'-CCA TCA CCA TCT TCC AGG AGC GA-3', 5'-GGA TGA CCT TGC CCA CAG CCT TG-3' and the following PCR protocol applied: 3 min initial denaturation and activation of the iTaq DNA polymerase at 95°C, followed by 45 cycles of denaturation (20 s at 95°C), annealing (30 s at 65°C) and elongation (30 s at 72°C).
After that melting curve analysis was performed in order to confirm the homogeneity of the PCR product by continuous measuring and slowly decreasing the temperature from 95°C to 60°C. For exact quantification standard curves were generated for each target gene used as external standards. Specific amplicons of each target gene were cloned into the vector pCR2.1 (Invitrogen, Karlsruhe, Germany) following the vendors instruction, sequenced and serial dilutions (1 x 10 6 -1 x 10 2 single stranded DNA molecules) were prepared and used as template applying the above quantitative PCR approach. GAPDH mRNA was used as internal standard to normalize MAO-A mRNA. Each sample was run in duplicate and the results represent the mean of three independent sets of experiments.
Conventional PCR was performed with a TECHNE TC-412 thermal cycler, using the Advantage 2 Polymerase Mix (Takara Bio Europe, France) according to the vendor's instructions. After 32 
RESULTS
The MAO-A isoform is predominant in SH-SY5Y cells
Dopaminergic SH-SY5Y cells have previously been reported to contain both MAO isoforms (Song and Ehrich, 1998) (Church et al. 1994; Rodriguez et al. 2000) and quantitative immunoassays (Sivasubramaniam et al. 2002) , whilst MAO-B protein was detected using a MAO-B-specific antibody (Billett and Mayer, 1986) . MAO-A but not MAO-B protein was detected in SH-SY5Y cells (Fig. 1B ) using immunohistochemical analysis with specific anti-MAO-A and MAO-B monoclonal antibodies.
In contrast, control human liver sections exhibited positive staining for MAO-A and -B (Fig.   1B ). Semi-quantitative reverse transcription-polymerase chain reactions (RT-PCR) revealed an intense signal for MAO-A indicating strong expression of the MAO-A messenger (Fig. 1C) . In contrast, no signal was observed for MAO-B messenger. Finally, using the more sensitive approach of quantitative RT-PCR (qRT-PCR), average MAO-A mRNA expression of 2.58±1.00 molecules/1000 molecules GAPDH was measured, whereas MAO-B mRNA levels were hardly detectable (0.0006±0.0005 molecules/1000 molecules GAPDH, data not shown).
STS induces an increase in MAO-A catalytic activity and protein levels prior to activation of caspase 3
In order to establish a model of neuronal apoptosis, SH-SY5Y cells were induced to undergo apoptotic cell death via the addition of staurosporine (STS). Initial titration studies established that 1 µM STS produced apoptotic cell morphologies (cellular blebbing etc.), but the cells were still viable after 6 h (MTT reduction assay, data not shown). Treatment with 1 µM STS consistently resulted in caspase-3 activation (approximately 7 fold of control levels at 3-6 h, Fig. 2 ). In addition, caspase-3 activation was preceded by a significant (2-3 fold) increase in MAO catalytic activity, suggesting that increased MAO activity could play a role in early Fig. 3A ).
MAO-A mRNA expression is not changed in STS-induced apoptosis
Quantitative reverse transcription-polymerase chain reactions (qRT-PCR) were performed to determine whether increases in MAO-A protein and activity were a result of increased MAO-A mRNA expression. No significant changes in MAO-A mRNA steady state levels were detected following 1 µM STS treatment over a three-h apoptotic time course (Fig.   3B ).
The intrinsic but not the extrinsic pathway is active in STS-induced Apoptosis
To investigate the upstream initiators of caspase-3, activation of caspase-8 and caspase-9 was monitored by Western blotting using specific antibodies directed against both the pro-and active-forms of caspases-8 and -9. Caspase-9 was activated, one h following STS exposure and remained active for the following 5 h (Data not shown; see Fig. 4 for 3 h time point). However, no activation of caspase-8 was detected, despite the presence of caspase 8 protein and caspase-8 mRNA as detected by Western blot and qRT-PCR respectively (data not shown).
Inhibition of MAO-A protects cells from STS-induced apoptosis
The MAO inhibitors clorgyline and tranylcypromine both inhibit in situ MAO activity in SH-SY5Y cells in the presence and absence of STS during a 4 h time period (Fig. 4A ). Caspase-3 activity was measured following inhibition of MAO-A in this apoptotic model to investigate the relevance of MAO in the apoptotic cascade. Both clorgyline and tranylcypromine (Fig. 4B) . Activation of the upstream initiator Caspase-9 during STS-induced apoptosis was significantly reduced to ~50 % by clorgyline, compared to STS treated cells alone (Fig. 4C ).
Inhibition of MAO-A also improves the viability of STS treated cells. Cell viability, measured using the MTT reduction assay, was reduced by 10% over a 3-h exposure to STS. The MAO inhibitors clorgyline and tranylcypromine reduced this effect, which was significant after 1 h (supplementary data, Figure S1A ). Morphological observations also demonstrated that inhibition of MAO-A improved viability. Figure S1B shows that after 3-h exposure, STS treatment results in a typical apoptotic phenotype, with cells being shrunk and rounded (compare panels a and d). The addition of clorgyline and tranylcypromine at the same time as STS significantly improved the condition of the cells, with axonal outgrowths being evident (compare panels b and c with respectively panels e and f).
Involvement of MAPK signalling pathways in MAO-enhanced apoptosis
MAPK phosphorylation cascades are activated following oxidative stress (Finkel, 1998) , are involved in the activation of MAO-B expression (Wong et al. 2002) and in pro-apoptotic MAO-A expression (DeZutter and Davis, 2001 ). To examine the potential involvement of MAPK signalling in MAO-enhanced apoptosis, we investigated the levels of phosphorylated (activated) protein kinases ERK, JNK and p38 during STS induced apoptosis. As shown in Figure 5A , STS resulted in sustained increases in the levels of phosphorylated ERK, JNK and p38 compared to controls, starting at approximately the same time as MAO activation (Figure 2 ).
Inhibition of MAO-A with clorgyline attenuated these effects, reducing the levels of 
Inhibition of MAO-A prevents Bcl-2 depletion during STS-Induced apoptosis
The Bcl-2 family of proteins are critical in apoptotic signalling because of their anti-and pro-apoptotic effects at the mitochondrial surface. As seen in Figure 5B , STS induced depletion of Bcl-2 levels and clorgyline alone had no effect on Bcl-2 levels. When the cells were exposed to clorgyline and STS together, Bcl-2 protein expression was maintained at the control level (Fig.   5B ).
Inhibition of MAO-A and addition of antioxidants has a similar effect on ROS formation and caspase-3 activation
MAO-A produces H 2 O 2 as a by-product of its enzymatic action. We hypothesised that MAO-A derived ROS might contribute to apoptotic signalling in our cell model. Hence antioxidants should mimic the effect of MAO-A inhibition in apoptotic signalling. Exposure of SH-SY5Y cells to 1 µM STS resulted in the production of high levels of ROS. This effect was lessened by concomitant treatment with 1 µM clorgyline or the anti-oxidant N-acetyl cysteine (NAC, 1 mM). However, 1 mM vitamin C was less effective (Fig. 6A) . NAC but not vitamin C significantly protected cells from caspase-3 activation (Fig. 6B ). These data indicate that MAOgenerated oxidative stress is involved in apoptotic signalling. 
DISCUSSION
In SH-SY5Y cells staurosporine activates caspase-9 and -3 and thus initiates the intrinsic apoptotic pathway. In contrast, the extrinsic route, which depends on agonist binding to cell surface death receptors, remained unaffected, despite the cells containing caspase 8 protein and also caspase 8 mRNA (data not shown). These data are consistent with previously reported results obtained in a similar cellular model (Lopez and Ferrer, 2000) . The activation of the mitochondrial apoptotic pathway in this model is of special interest considering the intracellular localisation of MAO in the outer mitochondrial membrane.
Our studies demonstrated that MAO-A activity was increased prior to caspase-3 activation and that inhibition of MAO activity significantly reduced caspase activation and loss in cell viability.
To improve the reliability of our experimental data we used two independent MAO inhibitors with different modes of action. Clorgyline preferentially inhibits MAO-A, but is structurally related to the MAO-B inhibitor deprenyl and other propargyl deprenyl analogues such as Npropargyl-1(R)-aminoindan (rasagiline) and the compound CGP3466 (now in clinical trials for PD). The propargylamine-containing deprenyl analogues have been reported to posses neuroprotective and anti-apoptotic properties (Holt et al. 2004; Akao et al. 2002; Tatton et al. 1994 ). These neuroprotective properties, rather than being a result of MAO inhibition, are thought to be due, at least partly, to the inhibition of pro-apoptotic translational machinery (Kragten et al. 1998; Berry and Boulton, 2000) , and induction of anti-apoptotic Bcl-2 family proteins (Kragten et al. 1998 ). Clorgyline has previously been shown to protect against apoptosis (DeZutter and Davis, 2001) , serum withdrawal-induced loss in cell viability (Ou et al. 2006) and MPTP induced neurotoxicity (DeGirolamo et al. 2001) . Whether or not the protective effects are 18 due solely to MAO inhibition has not been investigated. Indeed in our system clorgyline had no effect on Bcl-2 levels, at least in control cells. To confirm that the effects of clorgyline were a result of MAO inhibition, tranylcypromine was used as a second MAO inhibitor since it contains no propargyl moiety, but interacts irreversibly with the flavin group. Tranylcypromine inhibits both MAO-A and MAO-B but, because of the lack of MAO-B expression in our cell model, the protection of the cells from apoptosis can be attributed to its inhibition of MAO-A. This confirms that MAO-A is functional in neuronal cell apoptosis. Although a link between MAO and mitochondrial damage is well established (Berman and Hastings, 1999; Cohen and Kesler, 1999) and mitochondria are vital players in apoptotic signalling, a direct role for MAO-A in apoptosis has only been claimed by De Zutter and Davis (2001) and, very recently, by Ou (Ou et al. 2006 ).
However, these authors did not attempt to link the apoptotic effects to ROS production by MAO-A activity.
ROS formation was substantially increased following STS treatment and inhibition of MAO by
clorgyline and treatment with the antioxidant N-acetyl cysteine (NAC, a precursor of glutathione and an anti-oxidant in its own right) reduced ROS to a similar extent. The fact that both clorgyline and NAC also reduced caspase-3 activation indicates that ROS are the result of MAO activity. The anti-oxidant vitamin C was also used but was less effective than NAC or clorgyline in reducing both ROS production and caspase-3 activation. The reason for this is not clear but it may be related to the fact that vitamin C, although a potent anti-oxidant, is considered to be toxic in some circumstances, especially in the presence of metal ions and H 2 O 2 (reviewed by Halliwell, 1999) . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  P  e  e  r  R  e  v  i  e  w   19 MAO may be important in the early phase of apoptosis, before the execution of downstream processes, since peak MAO activity and ROS production occur prior to peak caspase-3 activity.
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Apoptosis is highly regulated, the mechanisms of which are still not fully understood, not only because there is a wide range of cell death types ranging between classical apoptosis to classical necrosis, but also because of variation depending on the nature of the inducer. However it is thought that apoptosis is the predominant form of neuronal cell death in chronic neurodegenerative diseases (Emerit et al. 2004) . Thus the fact that MAO has an active role in this process is of high significance.
We also demonstrate that MAO protein levels are increased, albeit transiently, and without a concomitant increase in MAO-A mRNA levels. This implies that in our apoptotic model, increases in MAO protein are due to post-transcriptional events. This could include a decrease in MAO protein degradation or an increase in mRNA translation. However little is known about these processes. In contrast, transcriptional activation of the MAO-A gene was seen following withdrawal of nerve growth factor in rat PC12 cells (DeZutter and Davis, 2001 , which has been related to pro-apoptotic signalling) and in SH-SY5Y cells (Fitzgerald et al, 2007) . In addition, Ou and co-workers (2006) recently found that MAO-A mRNA expression is also induced following serum starvation, mediated by a reduction in the expression of the transcriptional repressor R1. These different findings suggest that there are various regulatory mechanisms of cell death that could regulate MAO-A expression at different levels of gene expression.
Bcl-2 is an anti-apoptotic protein that plays a central role in mitochondrially mediated-apoptosis and survival due to its strong influence on the balance of pro-and anti-apoptotic proteins that 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 F o r P e e r R e v i e w 20 also reside on the mitochondrial surface. Depletion of Bcl-2 is thought to be one of the first initiators of the apoptotic cascade, since this shifts the balance of Bcl-2 family proteins in favour of apoptosis, triggering the release of cytochrome c from the mitochondria (Hengartner, 2000) .
STS exposure resulted in depletion of Bcl-2 levels in our model and was prevented by clorgyline, suggesting that MAO is acting upstream of Bcl-2. This is contrary to the situation in serum withdrawal, where MAO appears to act downstream of Bcl-2 (Ou et al. 2006) . However, these differences may reflect the different apoptotic inducers used and further work needs to be carried out to clarify this.
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